EVALUATION OF A NOVEL T CELL-DERIVED PEPTIDE FOR DELIVERY OF ANTISENSE OLIGONUCLEOTIDES TO TREAT DMD CARDIOMYOPATHY
$429,348FY2022Defense Health AgencyDOD
The Governors Of The University Of Alberta
Investigators
View source on USAspending →EVALUATION OF A NOVEL T CELL-DERIVED PEPTIDE FOR DELIVERY OF ANTISENSE OLIGONUCLEOTIDES TO TREAT DMD CARDIOMYOPATHY · GrantIndex